NCT05781711View on ClinicalTrials.gov

Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 6, 2023

Primary Completion Date

September 20, 2025

Study Completion Date

November 20, 2025

Conditions
Parkinson Disease
Interventions
DRUG

levodopa-carbidopa

levodopa-carbidopa is the standard therapy used in Parkinson's disease

DRUG

Metformin

Metformin, a biguanide family member commonly used in treatment for type 2 diabetes, appears to increase liver and peripheral tissue sensitivity to insulin as well as reduce hepatic glucose production

Trial Locations (1)

32511

RECRUITING

Faculty of Medicine, Menoufia University, Tanta

All Listed Sponsors
collaborator

Manal Ali Mahrous Hamouda Faculty of Pharmacy, Menufia University

UNKNOWN

lead

Tanta University

OTHER